Newsletter | August 5, 2022

08.05.22 -- Critical Risk Assessments With CDMOs

 
Featured Editorial
Industry Insights
How Oral Solid Coating Technologies Can Enhance Delivery Strategy

With increasing molecule complexity posing growing challenges for formulation and manufacture, oral solids specialists require extensive expertise and cross-team collaboration to ensure project success.

Putting Fill/Finish Customization Into Your Line Of Sight

This article discusses the manufacturing challenges and highlights the key considerations when evaluating product development tools, selecting equipment, and optimizing small-batch fill/finish lines.

Outsourcing Differences By Company Size: Biologic Drug Substance Manufacturing

ISR split the data from its most recent Biologic API CDMO Benchmarking report by large and non-large respondents to highlight the differences in outsourcing preferences and practices.

Leveraging Serialization Investments With Aggregation

Although most current legislation concerning traceability of pharma products focuses on serialization rather than aggregation, the latter is an essential component of internal and external traceability of products.

Case Study: Recovering A Clinical Trial That Has Been Derailed

When replacing your CRO becomes the only feasible option, a partner experienced in such transitions — as well as sensitive to the impact on your timeline and costs — is invaluable.

How To Make Solid Dose Pharmaceutical Tablets
In this article, we cover the basics of manufacturing these tablets that start out in research and development, an independent lab, a CDMO, or brand name manufacture.
Real-Time Visibility In Pharmaceutical Manufacturing: Needs And Solutions

We take a deep dive into real-time visibility and consider the top needs faced by three major players in pharma manufacturing: quality assurance, supervisors, and operators.

Top Ten Frequently Asked Questions On Feeder Accuracy

An introduction to the principles and practices of bulk solids feeding.

Self-Medication: Flexibility For Patients And Drug Manufacturers

Patients want a better quality of life and more freedom of choice, and manufacturers want to fulfill this wish with flexible equipment. Self-medication is a good example of how this can be implemented.

The New Pharma Imperative: Quality Flexibility

Informed quality leaders who stay abreast of the trends shaping the industry’s future will be critical drivers of transformation, versatility, and success within their organizations.

Understanding Perfusion Terminology

To evaluate whether a perfusion application will work in a production process, standardized terminology is critical. This white paper explains key terms that are essential for understanding the process.

Designing Efficiency Into Your AAV Process

Meeting demand for high-quality, adeno-associated virus requires scalable, cost-effective production. The process we developed optimizes each step from suspension cell culture to purified bulk.

Regulatory, Cost Implications Of Switching Injectable Delivery Formats

Launching a large molecule in one format and then switching the delivery format often transpires as a lifecycle management strategy for cost-efficiency, supply chain continuity, and patient benefit.

CMC Strategy To Take Bispecifics From DNA To IND In 13 Months

Review key approaches and technologies that enable a DNA to IND timeline, with case study examples for application in vector, process, analytic, and formulation development of bispecific molecules during preclinical development.

Scalable Solutions For Container Closure Integrity Testing

Learn alternative technology options and data integrity compliance capabilities that are critical to CCIT due to a wide variety of applications and regulatory requirements.

Solutions
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.